Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Essen University Hospital

6 abstracts

Abstract
Durvalumab and tremelimumab versus doxorubicin in previously untreated patients with advanced or metastatic soft tissue sarcoma: Patient-reported outcomes (PROs) of the randomized phase II MEDISARC study (AIO-STS-0415).
Org: Interdisciplinary Genitourinary Oncology at the West-German Cancer Center, Clinic for Urology, Essen University Hospital, Medizinische Klinik Abteilung II, Uniklinik Tubingen,
Abstract
Health-related quality of life (HR-QOL) measures in renal cell carcinoma (RCC): Patient-reported relevance of items of the FKSI-19, EORTC QLQ-C30, and EQ-5D.
Org: Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Rio De Janeiro, Brazil, City of Hope Comprehensive Cancer Center, Centro de Cancer de Brasilia, Instituto Unity de Ensino e Pesquisa, Grupo Oncoclinicas,
Abstract
Determinants of permanent liver limited disease (pLLD) in metastatic colorectal cancer (mCRC).
Org: Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Hospital Vall Hebron, Paul Brousse Hospital, Centro Hospitalar Universitário de Lisboa Central, Queen Elizabeth Hospital Birmingham,
Abstract
T-Rex study: Quality of life assessment using novel CTCAE-PRO and FKSI-19 in first-line treatment of metastatic renal cell carcinoma with tivozanib.
Org: Essen University Hospital, West German Cancer Center, University Hospital Essen, Clinic for Medical Oncology & Clinic for Urology, Urologisch-onkol. Schwerpunktpraxis Bernburg, Praxisnetzwerk Hämatologie und internistische Onkologie,
Abstract
Incidence and survival of oropharyngeal carcinoma patients and the development of HPV-testing prevalence in North Rhine-Westphalia: A Cancer Registry analysis from 2008-2018.
Org: University of Duisburg/Essen, Cancer Registry North Rhine-Westphalia, Cancer Registry of North Rhine-Westphalia, West German Cancer Center, University Hospital Essen, University Hospital Essen,
Abstract
Multi-modal and longitudinal characterization of the tumor and immune microenvironment from primary to in-transit and distant metastasis in acral melanoma.
Org: Dana-Farber Cancer Institute, Universitatsklinikum Essen Klinik fur Dermatologie, Laboratory of Systems Pharmacology, Harvard Medical School, Department of Applied Computational Cancer Research,